The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Management of early-stage breast cancer: Are we headed in the right direction?
U. Zurawska
No relevant relationships to disclose
D. A. Baribeau
No relevant relationships to disclose
C. Victor
No relevant relationships to disclose
S. Giilck
No relevant relationships to disclose
A. Florescu
No relevant relationships to disclose
S. Gandhi
No relevant relationships to disclose
S. Verma
Honoraria - GlaxoSmithKline; Roche; Sanofi
Research Funding - Roche; Sanofi